Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy.
Dörr
Wolfgang
W
Department of Radiotherapy and Radiation Oncology, Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany. Wolfgang.Doerr@tu-dresden.de
Jaal
Jana
J
Zips
Daniel
D
D001918:Brachytherapy / Q000009:adverse effects; D019583:Dose Fractionation, Radiation; D006801:Humans; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000209:etiology; D011879:Radiotherapy Dosage; D020266:Radiotherapy, Conformal / Q000009:adverse effects; D050397:Radiotherapy, Intensity-Modulated; D016032:Randomized Controlled Trials as Topic; D012007:Rectum / Q000528:radiation effects; D012307:Risk Factors; D013997:Time Factors; D001743:Urinary Bladder / Q000528:radiation effects